The noradrenaline transporter antibodies were generated against unique N-terminal peptides that are unique to the noradrenaline transporter protein. The antibodies are raised utilizing linear, multiple antigenic peptides or cyclic peptide methodology.
Our Abpromise guarantee covers the use of ab41559 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/500 - 1/1000. Detects a band of approximately 80 kDa (predicted molecular weight: 70 kDa).|
|ICC/IF||Use a concentration of 5 µg/ml.|
ab41559 has not yet been referenced specifically in any publications.